BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma

Genes Chromosomes and Cancer

Volumn 52, Issue 8, 2013, Pages 748-752

  Affolter, Kajsa ^a   Samowitz, Wade ^a,b   Tripp, Sheryl ^b   Bronner, Mary P ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MONOCLONAL ANTIBODY;

ARTICLE; CANCER CELL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CYTOPLASM; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PYROSEQUENCING; SENSITIVITY AND SPECIFICITY; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; GERM-LINE MUTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; POINT MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; TUMOR MARKERS, BIOLOGICAL;

EID: 84879254737     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22070     Document Type: Article

References (19)

1. Adackapara CA, Sholl LM, Barletta JA, Hornick JL. 2013. Immunohistochemistry using a BRAF V600E mutation-specific monoclonal antibody is not a useful surrogate for genotyping in colorectal adenocarcinoma. United States and Canadian Academy of Pathology Annual Meeting, Modern Pathology 26:140.
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. 2002. Mutations of the BRAF gene in human cancer. Nature 417:949-954.
3. De Roock W, Claes B, Bernasconi D. 2010. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis. Lancet Oncol 753-762.
4. Domingo E, Niessen R, Oliveira C, Alhopuro P, Moutinho C, EspA-n E, Armengo M, Sijmons R, Kleieuker J, Seruca R, Aaltonen L, Imai K, Yamamoto H, Schwartz S, Hofstra R. 2005. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes. Oncogene 3995-3998.
5. English DR, Young JP, Simpson JA, Jenkins MA, Southey MC, Walsh MD, Buchanan DD, Barker MA, Haydon AM, Royce SG, Roberts A, Parry S, Hopper JL, Jass JJ, Giles GG. 2008. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 17:1774-1780.
6. Koperek O, Kornauth C, Capper D, Berghoff A, Asari R, Niederle B, von Deimling A, Birner P, Preusser M. 2012. Immunohistochemical detection of the BRAF V600E-mutated protein in papilary thyroid carcinoma. Am J Surg Pathol 844-850.
7. Kuan SF, Pai RK, Navina S, Nikiforova MN, Cressman KL. 2013 Assessment of BRAFV600E mutation-specific antibody (VE1) in colorectal cancers. United States and Canadian Academy of Pathology Annual Meeting, Modern Pathology 26:161.
8. Long G, Wilmott J, Capper D, Preusser M, Zhang Y, Thompson J, Kefford R, von Deimling A, Scolyer R. 2013. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol 61-65.
9. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T, Yamashita S. 2003. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88:4393-4397.
10. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, Giovannucci EL, Fuchs CS. 2009. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58:90-96.
11. Pai R, Jayachandran P, Koong A, Chang D, Kwok S, Ma L, Arber D, Balise R, Tubbs R, Shadrach B, Pai R. 2012. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am J Surg Pathol 744-752.
12. Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen R, Bardelli A, Bernards R. 2012. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature 100-103.
13. Rajagopalen H, Bardelli A, Lengauer C. 2002. RAF/RAS oncogenes and mismatch-repair status (Letter). Nature 418:934.
14. Samowitz W, Sweeny C, Herrick J, Albertsen H, Levin T, Murtaugh M, Wolff R, Slattery M. 2005. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 6063-6069.
15. Sommerer F, Hengge UR, Markwarth A, Vomschloss S, Stolzenburg JU, Wittekind C, Tannapfel A. 2005. Mutations of BRAF and RAS are rare events in germ cell tumours. Int J Cancer 113:329-335.
16. Vaughn CP, Zobell SD, Furtado LV, Baker CL, Samowitz WS. 2011. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer 50:307-312.
17. Vakiani E, Zhou Y, Klimstra DS, Shia J. 2013. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal adenocarcinoma. United States and Canadian Academy of Pathology Annual Meeting, Modern Pathology 26:185.
18. Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC. 2010. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: A population-based study. Cancer Epidemiol Biomarkers Prev 19:1831-1839.
19. Yu J, Deshmukh H, Gutmann RJ, Emnett RJ, Rodriguez FJ, Watson MA, Nagarajan R, Gutmann DH. 2009. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 73:1526-1531.